I’ve done a few deals with the big boys and they hammer sources!
Lousy positioning, “we’ll try in on the bottom, see how you do, unless you want to drop your pricing”
“Can’t even talk at those price points”
Consignment game - “we’ll try it for 90 days, if we don’t re-order, we return inventory and pay you for what we did sell”
90 to 120 day payment terms
Pay a fortune to be in a Flyer AND drop pricing 50% for it.
Public doesn’t know the half of what goes on- retail is killer business. They have to pay for those stores, shiny floors, staff, management and shareholders....
These are why TV selling exploded and they want huge margins, which further supports the expensive retail debacle.
BIEL can be extremely successful because of the pain drug epidemic, it’s patented IP and >140 Million Americans with chronic and acute pain now realizing how harmful pain drugs really are.
TEVA gets the potential! Very progressive, very nimble- ActiPatch, drug-free, side-effect free, safe, efficacious, FDA says so and OTC cleared it and patented......and they did the deal! Soon....
Market Data 
Markets 
AI
